In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 68 for your search:
Drug:  isotretinoin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Unknown
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 0 to 18
Sponsor: NCI
Protocol IDs: CCG-3891

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: UCCRC-3723, ICC-82L4, NCI-V83-0135

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: MDA-DM-8489, NCI-V85-0151

5.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 40 to 75
Sponsor:
Protocol IDs: DCPC-CPSB-10305

6.

Phase: Phase III
Type: Prevention
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: NCOG-CC7H871J, RTOG-8910, NCI-C88-0001

7.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 21 to less than 85
Sponsor:
Protocol IDs: UARIZ-P89-0002, NCI-P89-0002

8.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 21 to less than 85
Sponsor:
Protocol IDs: UARIZ-CA34256, NCI-P89-0004

9.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 to 74
Sponsor: NCI
Protocol IDs: RTOG-9115, CLB-9499, SWOG-9446, MDA-CCOP-DM-90094, NCI-P91-0024, NCI-C91-0002, RTOG-91-15, MDA-C91-0002

10.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-91025, CLB-9293, E-91025, NCCTG-912452, RTOG-9101, SWOG-9221, I91-0001, INT-0125, NCI-P92-0014

11.

Phase: Phase III
Type: Prevention
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: EST-C-0590, MAYO-887451, NCCTG-887451, NCI-P92-0026

12.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MDA-DM-90096, NCI-V93-0310

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000271174, ECOG-1301, E1301, NCT00054561

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: ACNS0231, COG-ACNS0231, CDR0000353207, NCI-2012-02578, U10CA098543, NCT00078988

15.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 3 to 21
Sponsor: NCI, Other
Protocol IDs: ACNS0332, NCI-2009-00336, COG-ACNS0332, CDR0000511991, U10CA098543, R01CA114567, NCT00392327

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 and under
Sponsor: NCI, Other
Protocol IDs: ANBL0531, COG-ANBL0531, CDR0000554708, NCI-2009-00400, NCT00499616

17.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: ANBL0532, COG-ANBL0532, CDR0000576571, NCT00567567

18.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-2011-01997, ANBL0931, U10CA098543, COG-ANBL0931, NCT01041638

19.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor: NCI
Protocol IDs: EST-PC-483, EST-P-C483

20.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor: NCI
Protocol IDs: UARIZ-8567, NCI-T85-0215D, T85-0215

21.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI, NIAMS
Protocol IDs: NIAMS-91-AR-0093, NCI-T90-0133N, T90-0133

22.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00095, NYWCCC-0511008257, CDR0000472916, NCI-6896, 0511008257, 6896, P30CA013330, N01CM62204, NCT00324740

23.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0709, NCT00555399

24.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Under 21
Sponsor: Other
Protocol IDs: 22053-CHESAT, NCT00703222

25.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 8 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: DIV-NB-201, NCT01592045
1    
New Search